An Efficient Protocol to Assess ERK Activity Modulation in Early Zebrafish Noonan Syndrome Models via Live FRET

Giulia Fasano1, Valeria Bonavolontà2, Catia Pedalino2

  • 1Research laboratories, Ospedale Pediatrico Bambino Gesù, IRCCS.

Insights

Researchers developed a rapid zebrafish model to study RASopathies, genetic disorders caused by ERK hyperactivation. This model allows real-time monitoring of ERK activity and testing of potential treatments for these conditions.

Area of Science:

  • Genetics
  • Developmental Biology
  • Biochemistry

Background:

  • RASopathies are a group of genetic disorders characterized by ERK hyperactivation, leading to multisystemic diseases and increased cancer risk.
  • Germline gain-of-function mutations in RAS-MAPK pathway regulators are the primary cause of RASopathies, with new variants continually being identified.

Purpose of the Study:

  • To establish a rapid, in vivo method for functional validation of RAS-MAPK pathway variants.
  • To create a scalable and cost-effective preclinical model for testing therapeutic interventions in RASopathies.

Main Methods:

  • Generation of transient RASopathy models in zebrafish embryos using a transgenic ERK reporter.
  • Real-time multispectral Förster resonance energy transfer (FRET) imaging to monitor ERK activity during gastrulation.
  • Pharmacological modulation of ERK signaling using MEK inhibitors and assessment of FRET signal changes.
  • Cross-validation with immunofluorescence and analysis of morphometric parameters for gastrulation defects.

Main Results:

  • Demonstrated successful generation of Noonan syndrome zebrafish models expressing Shp2D61G.
  • Successfully registered changes in ERK signaling before and after MEK inhibitor treatment in real-time.
  • Validated live FRET imaging results with classical immunofluorescence and observed impaired gastrulation in affected embryos.

Conclusions:

  • The developed zebrafish model provides a rapid and reliable platform for studying RASopathies and validating disease-associated variants.
  • This method enables live monitoring of ERK activity and assessment of drug efficacy, facilitating preclinical research and drug repurposing for RASopathies.

Related Concept Videos